Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 329.01 ACUITE BB- | Stable | Reaffirmed -
Bank Loan Ratings 15.99 - ACUITE A4 | Reaffirmed
Total Outstanding 345.00 - -
Total Withdrawn 0.00 - -
 
Rating Rationale

Acuité has reaffirmed its long-term rating at 'ACUITE BB-' (read as ACUITE double B minus) and short-term rating at ‘ACUITE A4’ (read as ACUITE A four) on the Rs. 345.00 crore bank facilities of Premium Medical and Health Care Providers Private Limited (PMPL). The outlook is ‘Stable'.

Rating Reaffirmation
The rating reaffirmation factors in the steady operating performance of the company albeit improvement in operating margins. Further, the rating draws support from the extensive experience of the promoter group in the healthcare industry. However, the rating remained constrained on account of company’s stretched liquidity, with continuous losses at net level which led to insufficient net cash accruals against its maturing debt obligations wherein repayments are supported by infusion of quasi equity. Further the rating factors in company’s weak financial risk profile and stringent regulatory framework in the healthcare industry.


About the Company

Premium Medical and Health Care Providers Private Limited (PMPL), based out of Coimbatore, Tamil Nadu was incorporated in September, 2013 and commenced commercial operations in September, 2017. The Company runs a multi-specialty hospital under the name “Meitra” located in Calicut, Kerala. The total built up area of the hospital at present is nearly 400,000 sq. ft. with capacity of 270 beds of which it is operating with 220 beds for in-patients. The company is promoted by KEF Healthcare Services Pte Limited, which in-turn is promoted by Mr. K.E. Faizal and the promoters of Peekay Group i.e. Mr. K.E Shanavaz, Mr. K.E Moidu and Mr. P.K. Ahammed.

 
Unsupported Rating
­Not Applicable
 
Analytical Approach
­Acuité has taken a standalone view of the business and financial risk profile of PMPL to arrive at the rating.
 
Key Rating Drivers

Strengths

­Extensive experience of promoters
PMPL is promoted by KEF Healthcare Services Pte Limited, and Peekay Group. KEF Healthcare Pte Limited is into managing a chain of hospitals and provide consultancy and management services and is a wholly owned subsidiary of KEF Holdings engaged into infrastructure, healthcare and investments across India and UAE. KEF Holdings incorporated in Singapore & headquartered in Dubai specializes in offsite manufacturing technology in industries, including healthcare, education, sports and agriculture led by Mr. Faizal E. Kottikollon, an industrialist who has a diversified experience of more than a decade across various industries. Mr. Faizal Kottikollon founded Emirates Techno Casting in Sharjah back in 1997. In 2012, Emirates Techno Casting was sold to Tyco International for over $400 m. This capital was then used to create KEF Holdings. Dr. Ali Faisal is an experienced cardiologist in North Kerala with special interest in non-coronary and peripheral vascular intervention for more than 20 years. The promoters of Peekay group through its group companies are present across various sectors such as steel, flour mills, real estate,construction, plantations,education, healthcare,charitable institution etc.

Improvement in operating performance in 11MFY25
The company reported an improvement in average revenue per occupied bed (ARPOB) per day and overall occupancy level in 11MFY25. The ARPOB improved to Rs.55719 in 11MFY25 from Rs.53748 in FY2024 and Rs.46785 in FY2023. The occupancy level stood at 70 per cent, 56 per cent and 63 per cent respectively for the corresponding period. Although these parameters shown improvement, the company reported marginal improvement in revenue of Rs. 237 Cr. in FY2025 (Est.), Rs.200.37 Cr. in FY2024 against Rs. 222.80 Cr. in FY2023. This improvement in operating performance in 11MFY25 is mainly driven by increased rack rates on billable items, hiring of doctors in-house vis-à-vis on consultation basis earlier, optimisation of costs by entering in long term contract on fixed percentage basis etc. The operating margin stood at 6.10 percent in FY2024 as against 5.41 percent in FY2023. The PAT stood at Rs. (41.97) Cr. in FY2024. In 11MFY25 the operating margin stood at 17.61 per cent, However, the company estimated losses at PAT levels, the PAT margin for 11MFY25 stood at -2.03 per cent.  Acuite believes this improvement in operating performance will sustain over the near to medium term on the back of structural improvements in the overall business risk profile, hwever improvement in profitability while sustaining revenue growth would remain a key rating monitorable.


Weaknesses

Weak financial risk profile 
Financial risk profile of the company continues to remain weak marked by high gearing (debt to equity ratio) and weak debt protection metrics. During the year FY2024, the tangible net worth declined and stood at Rs.53.33 Cr. as on March 31, 2024 from Rs. 58.76 Cr. as on March 31, 2023 on account of accrued losses. The total debt stood at Rs. 315.38 Cr. as on March 31, 2024 which includes long-term borrowing of Rs.297.76 Cr. and Rs.17.62 Cr. of short-term borrowing. The overall gearing of the company stood at 5.91 times as on March 31, 2024 as against 5.54 times as on March 31, 2023. The coverage indicators continued to remain weak marked by below unity where the DSCR stood at 0.32 times in FY2024 as against 1.45 times in FY2023 and interest coverage ratio of 0.32 times in FY2024 as against 0.28 times in FY2023. Debt/EBITDA stood high at 24.58 days in FY24 as against 26.12 days in FY2023. The company converted its ECBs into equity of Rs.137.19 Cr. and infused additional equity around ~Rs.30 Cr. as on 31st March 2025. With this the gearing and debt protection metrics are expected to improve to an extent, however they will remain sub dued to continued losses.

­Stringent regulatory framework in the healthcare sector
Despite the increasing trend of privatization of healthcare sector in India, the company continues to operate under stringent regulatory environment. Accordingly, regulatory challenges continue to pose a significant risk to private healthcare institutions, as they are highly susceptible to changes in regulatory framework. Healthcare is a highly sensitive sector where any mishandling of a case or negligence on part of any doctor and/or staff of the unit can lead to distrust among the masses. Thus, the healthcare providers need to monitor each case diligently and maintain standard in services in order to avoid the occurrence of any unforeseen incident. They also need to maintain high vigilance to avoid any malpractice in any pocket.

Rating Sensitivities
  • Substantial improvement in operating performance that enables the company to generate adequate cash accruals in line with its repayment obligations.

  • Changes in financial risk profile owing to higher-than-expected debt funded capex  

  • Any elongation in working capital cycle

 
Liquidity Position
Stretched

The company has a stretched liquidity position marked by inadequate net cash accruals against maturing debt obligations in FY24. The company has inadequate net cash accruals of Rs. (22.69) crore in FY24 against maturing debt obligations of Rs.14.94 crore over the same period. However, the net cash accruals are expected to improve but expected to remain inadequate in FY2025 and will stand in the range of Rs.14- to Rs. 15 Cr. as against debt obligations of Rs.18.35 Cr, the inadequacy will be supported by equity infusion. The company maintains unencumbered cash and bank balances of Rs.1.08 crore as on March 31, 2024. The current ratio stood at 0.29 times as on March 31, 2024. The average utilization of the bank limits of the company remains high and stood at 99 per cent in last 9 months ended February 2025.

 
Outlook: Stable
­
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 24 (Actual) FY 23 (Actual)
Operating Income Rs. Cr. 200.37 222.80
PAT Rs. Cr. (41.97) 3.53
PAT Margin (%) (20.94) 1.59
Total Debt/Tangible Net Worth Times 5.91 5.54
PBDIT/Interest Times 0.32 0.28
Status of non-cooperation with previous CRA (if applicable)
­Not Applicable
 
Interaction with Audit Committee anytime in the last 12 months (applicable for rated-listed / proposed to be listed debt securities being reviewed by Acuite)
Not applicable
Any other information
­None
 
Applicable Criteria
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm
• Service Sector: https://www.acuite.in/view-rating-criteria-50.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
28 Nov 2024 Bank Guarantee (BLR) Short Term 16.00 ACUITE A4 (Reaffirmed)
Secured Overdraft Long Term 11.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Term Loan Long Term 18.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Term Loan Long Term 157.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Term Loan Long Term 97.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Secured Overdraft Long Term 5.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Term Loan Long Term 15.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
Proposed Long Term Bank Facility Long Term 26.00 ACUITE BB- | Stable (Upgraded from ACUITE B+ | Stable)
12 Nov 2024 Bank Guarantee (BLR) Short Term 16.00 ACUITE A4 (Reaffirmed)
Secured Overdraft Long Term 11.00 ACUITE B+ | Stable (Upgraded from ACUITE C)
Term Loan Long Term 18.00 ACUITE B+ | Stable (Upgraded from ACUITE C)
Term Loan Long Term 157.00 ACUITE B+ | Stable (Upgraded from ACUITE C)
Term Loan Long Term 97.00 ACUITE B+ | Stable (Upgraded from ACUITE D)
Secured Overdraft Long Term 5.00 ACUITE B+ | Stable (Upgraded from ACUITE D)
Term Loan Long Term 15.00 ACUITE B+ | Stable (Upgraded from ACUITE C)
Proposed Long Term Bank Facility Long Term 26.00 ACUITE B+ | Stable (Upgraded from ACUITE C)
11 Nov 2024 Bank Guarantee (BLR) Short Term 16.00 ACUITE A4 (Downgraded from ACUITE A4+)
Term Loan Long Term 15.00 ACUITE C (Downgraded from ACUITE BB | Stable)
Term Loan Long Term 157.00 ACUITE C (Downgraded from ACUITE BB | Stable)
Term Loan Long Term 18.00 ACUITE C (Downgraded from ACUITE BB | Stable)
Secured Overdraft Long Term 11.00 ACUITE C (Downgraded from ACUITE BB | Stable)
Proposed Long Term Bank Facility Long Term 26.00 ACUITE C (Downgraded from ACUITE BB | Stable)
Secured Overdraft Long Term 5.00 ACUITE D (Downgraded from ACUITE BB | Stable)
Term Loan Long Term 97.00 ACUITE D (Downgraded from ACUITE BB | Stable)
04 Sep 2023 Bank Guarantee (BLR) Short Term 2.00 ACUITE A4+ (Reaffirmed)
Secured Overdraft Long Term 13.00 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Term Loan Long Term 49.50 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Term Loan Long Term 157.00 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Term Loan Long Term 100.00 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Secured Overdraft Long Term 5.00 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Term Loan Long Term 15.00 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
Proposed Long Term Bank Facility Long Term 3.50 ACUITE BB | Stable (Downgraded (Negative to Stable) from ACUITE BB+ | Negative)
07 Jun 2022 Bank Guarantee (BLR) Short Term 2.00 ACUITE A4+ (Reaffirmed)
Secured Overdraft Long Term 13.00 ACUITE BB+ | Negative (Reaffirmed)
Term Loan Long Term 49.50 ACUITE BB+ | Negative (Reaffirmed)
Term Loan Long Term 157.00 ACUITE BB+ | Negative (Reaffirmed)
Term Loan Long Term 100.00 ACUITE BB+ | Negative (Reaffirmed)
Secured Overdraft Long Term 5.00 ACUITE BB+ | Negative (Reaffirmed)
Term Loan Long Term 15.00 ACUITE BB+ | Negative (Reaffirmed)
Proposed Long Term Bank Facility Long Term 3.50 ACUITE BB+ | Negative (Reaffirmed)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Yes Bank Ltd Not avl. / Not appl. Bank Guarantee (BLR) Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 15.99 Simple ACUITE A4 | Reaffirmed
Not Applicable Not avl. / Not appl. Proposed Long Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 34.17 Simple ACUITE BB- | Stable | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Secured Overdraft Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 11.69 Simple ACUITE BB- | Stable | Reaffirmed
Federal Bank Not avl. / Not appl. Secured Overdraft Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 4.48 Simple ACUITE BB- | Stable | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Term Loan 30 Sep 2020 Not avl. / Not appl. 30 Apr 2033 12.37 Simple ACUITE BB- | Stable | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Term Loan 22 Mar 2021 Not avl. / Not appl. 15 Jan 2026 14.97 Simple ACUITE BB- | Stable | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Term Loan 27 Apr 2018 Not avl. / Not appl. 30 Apr 2033 156.83 Simple ACUITE BB- | Stable | Reaffirmed
Federal Bank Not avl. / Not appl. Term Loan 06 Sep 2021 Not avl. / Not appl. 30 Jun 2033 94.50 Simple ACUITE BB- | Stable | Reaffirmed

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in